Search Results - "Prka, Željko"
-
1
Atypical Plasma Cell Leukemia Mistaken for Acute Leukemia: A Case Report
Published in Medicina (Kaunas, Lithuania) (01-08-2024)“…The patient we present here had many clinical, morphological, and laboratory findings characteristic of acute leukemia. During the course of the disease, the…”
Get full text
Journal Article -
2
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients
Published in Wiener Klinische Wochenschrift (2022)“…Summary We retrospectively investigated clinical and prognostic significance of psoas muscle index (PMI) calculated as total psoas muscle area at L3 vertebra…”
Get full text
Journal Article -
3
Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients
Published in Croatian medical journal (01-02-2017)“…To assess the benefit of rituximab with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (R-DA-EPOCH) regimen as a…”
Get full text
Journal Article Paper -
4
Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome
Published in Hematology (Luxembourg) (15-03-2016)“…The recent availability of potent oral iron chelators is renewing an interest in the assessment of the possible impact of HFE genetics in MDS. Thirty six newly…”
Get more information
Journal Article -
5
Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
Published in Annals of Saudi medicine (01-05-2012)“…CD30+ T-cell lymphoproliferative disorders (LD) comprise two main groups of diseases: CD30+ LD of the skin and systemic anaplastic large cell lymphoma (ALCL)…”
Get full text
Journal Article -
6
Medical students' clinical skills do not match their teachers' expectations: survey at Zagreb University School of Medicine, Croatia
Published in Croatian medical journal (01-02-2006)“…To evaluate self-assessed level of clinical skills of graduating medical students at Zagreb University School of Medicine and compare them with clinical skill…”
Get full text
Journal Article -
7
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia
Published in Annals of hematology (01-06-2019)Get full text
Journal Article -
8
Dose‐adjusted EPOCH and rituximab (DA‐EPOCH‐R) in older patients with high‐risk aggressive diffuse large B‐cell lymphoma: A real‐life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)
Published in European journal of haematology (01-06-2023)“…Purpose Dose‐adjusted EPOCH and rituximab (DA‐EPOCH‐R) is a regimen used for the treatment of high‐risk diffuse large B‐cell lymphoma (DLBCL) designed to…”
Get full text
Journal Article -
9
-
10
Prognostic implications of low transferrin saturation in patients with primary myelofibrosis
Published in Leukemia research (01-03-2018)“…•Low transferrin saturation (TSAT ≤20%) is present in 1/3 of myelofibrosis patients.•Low TSAT is associated with microcytosis, but not hemoglobin level.•Low…”
Get full text
Journal Article -
11
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia
Published in Leukemia & lymphoma (20-03-2020)“…First obinutuzumab application is associated with infusion related reactions (IRRs) that may discourage further continuation of the drug. During our clinical…”
Get full text
Journal Article -
12
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis
Published in International journal of hematology (01-02-2018)“…Neoplastic megakaryopoiesis is a dominant feature of Philadelphia-chromosome-negative myeloproliferative neoplasms (Ph− MPNs), and elevated…”
Get full text
Journal Article -
13
The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis
Published in Acta haematologica (2016)Get more information
Journal Article -
14
Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis
Published in Clinical lymphoma, myeloma and leukemia (01-09-2016)“…Abstract Introduction Β-catenin is a central effector molecule of canonical Wnt signaling pathway. It is important for maintenance of stem cell homeostasis and…”
Get full text
Journal Article -
15
Focal myositis of lower extremity responsive to botulinum A toxin
Published in Clinical neuropharmacology (01-03-2014)“…Focal myositis is a rare, mostly benign disease (pseudotumor) of skeletal muscle, histopathologically characterized by interstitial myositis and tumorous…”
Get full text
Journal Article -
16
The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience
Published in Liječnički vjesnik (01-05-2014)“…AIM. In this study we presented our experience with peripherally inserted central venous catheter (PICC) in patients with hematological malignancies. In the…”
Get full text
Journal Article -
17
Carotid endarterectomy unexpectedly resulted in optimal blood pressure control
Published in Collegium antropologicum (01-12-2009)“…Resistant hypertension is defined as hypertension that remains above 140/90 mmHg despite the provision of three or more antihypertensive drugs in a rational…”
Get more information
Journal Article -
18
Medical Students’ Clinical Skills Do Not Match Their Teachers’ Expectations: Survey at Zagreb University School of Medicine, Croatia
Published in Croatian medical journal (15-02-2006)“…Aim: To evaluate self-assessed level of clinical skills of graduating medical students at Zagreb University School of Medicine and compare them with clinical…”
Get full text
Paper -
19
UPOTREBA PERIFERNO UVEDENOGA CENTRALNOG VENSKOG KATETERA (PICC) U BOLESNIKA SA ZLOĆUDNIM HEMATOLOŠKIM BOLESTIMA – PRIKAZ VLASTITIH ISKUSTAVA
Published in Liječnički vjesnik (30-06-2014)“…Cilj. Prikazati vlastita iskustva s upotrebom periferno uvedenoga centralnog venskog katetera (PICC) u bolesnika sa zloćudnim hematološkim bolestima. Metode. U…”
Get full text
Paper